| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022530 |
| Receipt No. | R000025969 |
| Official scientific title of the study | Multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for prostate cancer |
| Date of disclosure of the study information | 2016/05/30 |
| Last modified on | 2017/05/31 (Ver. 4) |
| Basic information | |||
| Official scientific title of the study | Multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for prostate cancer | ||
| Title of the study (Brief title) | Multi-institutional study of HDR combined with EBRT for prostate cancer | ||
| Region |
|
||
| Condition | |||
| Condition | prostate cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | to report the results of prostate cancer patients treated with high-dose-rate brachytherapy combined with external beam radiotherapy |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | biochemical disease free survival |
| Key secondary outcomes | cumulative toxicity rate
overall survival |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | na | |||
| Key exclusion criteria | na | |||
| Target sample size | 3000 | |||
| Research contact person | |
| Name of lead principal investigator | hiromichi ishiyama |
| Organization | kitasato university school of medicine |
| Division name | department of radiology and radiation oncology |
| Address | 1-15-1 kitasato sagamiharashi-minamiku |
| TEL | 042-778-8453 |
| hishiyam@kitasato-u.ac.jp | |
| Public contact | |
| Name of contact person | hiromichi ishiyama |
| Organization | kitasato university shool of medicine |
| Division name | department of radiology and radiation oncology |
| Address | 1-15-1 kitasato sagamiharashi-minamiku |
| TEL | 042-778-8453 |
| Homepage URL | |
| hishiyam@kitasato-u.ac.jp | |
| Sponsor | |
| Institute | kitasato univerisity |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japanese Group of Brachytherapy-Japanese Society for Radiation Oncology
Japanese Radiation Oncology Study Group Japan Agency for Medical Research and Development |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | High-dose-rate brachytherapy combined with external beam radiotherapy was an effective and safe treatment for localized prostate cancer. Combination of long-term ADT was suggested to be necessary, even for HDR brachytherapy, and was useful in suppressing late toxicities. Meanwhile, pelvic irradiation was suggested to have an adverse effect on OS of our study population. |
| Other related information | study design: multi-institutional retrospective analysis
Candidate: prostate cancer patients treated by high-dose-rate brachytherapy before 1995 and followed at least 2 years. Dead patients within 2 years are included. Method: review of medical record. Items: age, TNM stage, Gleason score, PSA value, history of TUR-p, with or without hormonal therapy, radiation dose, number of fractionations, type of external beam radiation therapy, follow up period, tumor control, survival period, toxicity rate |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000025969 |